UC Berkeley Fends off DTC Genomics Critics; Other Schools Mull Genetic Tests as Educational Tools
By Turna Ray,
GenomeWeb
| 05. 25. 2010
[Quotes CGS]
[updated May 26]
Going ahead with its plans to offer voluntary genetic testing to incoming freshman, the University of California, Berkeley, seems to not be deterred by numerous detractors of the direct-to-consumer genomics model who have criticized the effort.
UC Berkeley last week announced its plan to launch a voluntary program this fall that will test students in the Class of 2014 for three genes involved in the metabolization of alcohol, lactose, and folates. The announcement capped several controversial weeks for the DTC genomics sector, during which the marketing practices of Pathway Genomics brought regulatory action from the US Food and Drug Administration and spurred a congressional probe into the consumer genomics industry (PGx Reporter 05/19/10).
Upon announcing its gene testing plans as part of its "On the Same Page" program intended to introduce incoming students to an intellectual or thought-provoking experience, at least two organizations, the Center for Genetics and Society and the Council for Responsible Genetics, urged UC Berkeley to halt its plans.
In a statement on the CGS website, an analyst from the center pointed...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...